Goldfinch Bio Company

Goldfinch is a clinical-stage biotech company focused on discovering and developing precision therapies for patients with kidney disease.
Technology: COVID, Organoids
Industry: Preventive Tech, Providers
Headquarters: Cambridge, Massachusetts, United States
Founded Date: 2015-01-01
Employees Number: 11-50
Funding Status: N/A
Total Funding: 210000000
Estimated Revenue: $1M to $10M
Last Funding Type: Series B

Visit Website
Register and Claim Ownership